Evidence-based·Last reviewed May 30, 2026·How we grade evidence

Cerebrolysin

PeptideResearch peptide

Useful mainly for not established — investigational in the U.S..

Research compound — not an approved drug or dietary supplement

This compound is sold for research and is not FDA-approved for human use or as a dietary supplement. Human evidence is limited; purity and dosing of consumer products are unverified. The data below is an evidence review for education only — talk to a clinician before considering it.

Quick decision guide

May help most

Not established — investigational in the U.S.

Watch out for

Not FDA-approved; biologically sourced with variable composition and mixed/inconclusive independent evidence

What is it

Cerebrolysin is a peptide preparation derived from purified porcine brain proteins, proposed to have neurotrophic and neuroprotective effects by mimicking the action of nerve growth factors. It is approved and used in several countries (parts of Europe, Asia, and elsewhere) for indications such as stroke and dementia, but it is NOT FDA-approved in the United States, and independent meta-analyses have reached mixed or inconclusive findings about its clinical benefit. As a U.S.-imported 'research' product it is unregulated, and because it is biologically sourced its purity and composition can vary; it is not a dietary supplement and is sold only 'for research use only' domestically.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Probably skip if…

You expect a U.S.-approved or clearly proven neurological therapy — it is not FDA-approved and evidence is mixed
You would source it from 'research use only' vendors with no U.S. regulatory oversight
You are not prepared for variability inherent to a porcine brain-derived biological product
You are uncomfortable with self-injection/infusion risks such as infection, hypersensitivity, and contamination
You want to avoid legal gray areas around importing an unapproved drug

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Reported in clinical use abroad: injection-site reactions, headache, dizziness, sensations of heat/flushing, and (with rapid administration) agitation

Serious risks

  • Unregulated supply and variable composition of an animal-sourced biological in the U.S.

  • Hypersensitivity/allergic reactions, including the potential for severe reactions

  • Theoretical contamination risk from a biologically derived, non-FDA-overseen product

  • Mixed/inconclusive independent evidence for the claimed neurological benefits

Who should avoid it

  • Anyone using it without direct medical supervision
  • Pregnancy and breastfeeding
  • People with severe kidney impairment or epilepsy (cautioned in product labeling abroad)
  • Anyone with known hypersensitivity to the preparation

Pregnancy & breastfeeding

Avoid — no adequate safety data.

Choosing a product

What to look for on the label — and what to be skeptical of.

Be skeptical of…

'Proven' or 'cure' claims for stroke, dementia, or brain injury (independent evidence is mixed)
Implying U.S. FDA approval
Vendors selling imported/'research use only' product for human use without oversight

Track Cerebrolysin with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: This compound is not approved by the FDA for human use and is not a dietary supplement. This page is an educational review of available research — much of it preclinical or early-stage — not a recommendation to use it. Consumer product quality is unregulated. Consult a qualified clinician.